Notably, among the 5 MCL patient specimens evaluated before and after SCR treatment, CXCL9 expression increased in one patient, whereas the other patients did not exhibit significant increases in expression (Supplementary Figure 2). Here, CXCL9 is linked to mantle cell lymphoma.